Cargando…
ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation
BACKGROUND: Small cell lung cancer (SCLC) is the most aggressive form of lung cancer, and new molecular insights are necessary for prognostic and therapeutic advances. METHODS: Dopamine and cAMP-regulated phosphoprotein, Mr 32000 (DARPP-32) and its N-terminally truncated splice variant, t-DARPP, wer...
Autores principales: | Alam, Sk. Kayum, Wang, Li, Ren, Yanan, Hernandez, Christina E., Kosari, Farhad, Roden, Anja C., Yang, Rendong, Hoeppner, Luke H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463034/ https://www.ncbi.nlm.nih.gov/pubmed/32499571 http://dx.doi.org/10.1038/s41416-020-0923-6 |
Ejemplares similares
-
DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration
por: Alam, Sk. Kayum, et al.
Publicado: (2018) -
IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity
por: Alam, Sk. Kayum, et al.
Publicado: (2023) -
DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma
por: Alam, Sk. Kayum, et al.
Publicado: (2021) -
Darpp-32 and t-Darpp are differentially expressed in normal and malignant mouse mammary tissue
por: Christenson, Jessica L, et al.
Publicado: (2014) -
DARPP-32: from neurotransmission to cancer
por: Belkhiri, Abbes, et al.
Publicado: (2016)